Geode Capital Management
TRIB

Geode Capital Management’s Trinity Biotech TRIB Stock Holding History

Geode Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.02K Hold
16,642
– – ﹤0.01% 4493
2025
Q4 		$13.2K Hold
16,642
– – ﹤0.01% 4419
2025
Q3 		$17.3K Hold
16,642
– – ﹤0.01% 4428
2025
Q2 		$11K Hold
16,642
– – ﹤0.01% 4414
2025
Q1 		$9.48K Sell
16,642
-1,033
-6% -$815 ﹤0.01% 4434
2024
Q4 		$15.6K Buy
+17,675
New +$23.6K ﹤0.01% 4404
2021
Q3 		– Sell
-2,782
Closed -$40K – 4872
2021
Q2 		$40K Hold
2,782
– – ﹤0.01% 4678
2021
Q1 		$52K Hold
2,782
– – ﹤0.01% 4399
2020
Q4 		$52K Hold
2,782
– – ﹤0.01% 4164
2020
Q3 		$27K Hold
2,782
– – ﹤0.01% 4099
2020
Q2 		$30K Hold
2,782
– – ﹤0.01% 4046
2020
Q1 		$15K Hold
2,782
– – ﹤0.01% 4057
2019
Q4 		$14K Hold
2,782
– – ﹤0.01% 4180
2019
Q3 		$16K Hold
2,782
– – ﹤0.01% 4162
2019
Q2 		$25K Hold
2,782
– – ﹤0.01% 4148
2019
Q1 		$39K Hold
2,782
– – ﹤0.01% 4051
2018
Q4 		$31K Hold
2,782
– – ﹤0.01% 4056
2018
Q3 		$55K Hold
2,782
– – ﹤0.01% 4021
2018
Q2 		$69K Buy
+2,782
New +$66.9K ﹤0.01% 3939
2017
Q2 		– Sell
-4,808
Closed -$142K – 4110
2017
Q1 		$142K Sell
4,808
-2,430
-34% -$76K ﹤0.01% 3749
2016
Q4 		$249K Buy
7,238
+5,048
+231% +$174K ﹤0.01% 3540
2016
Q3 		$144K Buy
2,190
+13
+0.6% +$809 ﹤0.01% 3705
2016
Q2 		$123K Hold
2,177
– – ﹤0.01% 3737
2016
Q1 		$126 Sell
2,177
-139
-6% -$7.38K ﹤0.01% 3771
2015
Q4 		$135K Buy
+2,316
New +$137K ﹤0.01% 3804

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management's TRIB Position: Q1 2026 in Review

Geode Capital Management held its Trinity Biotech (TRIB) position steady in Q1 2026 at 16,642 shares worth $9.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4493.

Geode Capital Management first reported a position in TRIB in Q4 2015 and has held it in 25 quarters since. The position peaked at $249K in Q4 2016. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Geode Capital Management held 16,642 shares of Trinity Biotech worth $9.02K as of Q1 2026.
  • Geode Capital Management left its Trinity Biotech share count unchanged in Q1 2026.
  • Trinity Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4493 holding.
  • Geode Capital Management first reported a position in Trinity Biotech in Q4 2015 and has held it in 25 quarters since.
  • Geode Capital Management's Trinity Biotech position peaked at $249K in Q4 2016.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.